Skip to main content
SpringerLink
Log in

Drug-Induced Aseptic Meningitis and Other Mimics

  • Chapter
  • First Online:
CNS Infections

  • 1283 Accesses

Abstract

Meningitis refers to inflammation of the cerebrospinal fluid (CSF) and the meninges that surround the brain and spinal cord. Aseptic meningitis or viral meningitis has a benign, self-limited course. Aseptic meningitis can result from noninfectious causes such as medications or systemic conditions. Drugs that have been implicated as possible causes of aseptic meningitis (drug-induced meningitis or DIAM) include nonsteroidal anti-inflammatory drugs, antibiotics, immunosuppressants, and antiepileptic drugs, although monoclonal antibodies have emerged as culprit of DIAM. Systemic lupus erythematosus (SLE) stands as the single most frequent underlying condition associated with DIAM. The pathogenic mechanisms of DIAM are not fully understood, but there is evidence to suggest that they may be diverse, perhaps different for the various types of drugs. Most of the authors invoke a hypersensitivity mechanism (especially type 1 and 3). Medication-induced aseptic meningitis must remain a diagnosis of exclusion after other more common infectious causes have been effectively excluded. Thus, a thorough history on prior drug intake is key to avoid expensive diagnostic procedures or lengthy and unnecessary treatments. In cases where bacterial meningitis is a possibility, we suggest to treat the patient with a third-generation cephalosporin, only rarely linked to DIAM and active against the most likely organisms of community-acquired meningitis. Aside from DIAM, several systemic and neurological disorders, including SLE, sarcoidosis, Behçet disease, Sjögren’s syndrome, and primary angiitis of the central nervous system, may also mimic infectious meningitis; therefore, differentiating from infectious meningitis is difficult, particularly considering the similar CSF profile and clinical presentation making the etiological diagnosis and management of these patients challenging.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jolles S, Sewell WA, Leighton C. Drug-induced aseptic meningitis: diagnosis and management. Drug Saf. 2000;22(3):215–26.

    Article  CAS  PubMed  Google Scholar 

  2. McGill F, Heyderman RS, Panagiotou S, Tunkel AR, Solomon T. Acute bacterial meningitis in adults. Lancet. 2017;388(10063):3036–47.

    Article  Google Scholar 

  3. Moris G, Garcia-Monco JC. The challenge of drug-induced aseptic meningitis revisited. JAMA Intern Med. 2014;174(9):1511–2.

    Article  PubMed  Google Scholar 

  4. Creel GB, Hurtt M. Cephalosporin-induced recurrent aseptic meningitis. Ann Neurol. 1995;37(6):815–7.

    Article  CAS  PubMed  Google Scholar 

  5. Nakajima W, Ishida A, Takahashi M, Sato Y, Ito T, Takada G. Aseptic meningitis associated with cephalosporins in an infant with trisomy 21. J Child Neurol. 2007;22(6):780–2.

    Article  PubMed  Google Scholar 

  6. Khan S, Sharrack B, Sewell WA. Metronidazole-induced aseptic meningitis during Helicobacter pylori eradication therapy. Ann Intern Med. 2007;146(5):395–6.

    Article  PubMed  Google Scholar 

  7. Corson AP, Chretien JH. Metronidazole-associated aseptic meningitis. Clin Infect Dis. 1994;19(5):974.

    Article  CAS  PubMed  Google Scholar 

  8. Mondon M, Ollivier L, Daumont A. Aseptic meningitis ornidazole-induced in the course of infectious endocarditis. Rev Med Interne. 2002;23(9):784–7.

    Article  CAS  PubMed  Google Scholar 

  9. Audemard A, Le Bellec ML, Carluer L, Dargere S, Verdon R, Castrale C, et al. Fumagillin-induced aseptic meningoencephalitis in a kidney transplant recipient with microsporidiosis. Transpl Infect Dis. 2012;14(6):E147–9.

    Article  CAS  PubMed  Google Scholar 

  10. Tuleja E, Bourgarit A, Abuaf N, Le Beller C, Sereni D. Rifampin-induced severe aseptic meningitis. Rev Med Interne. 2010;31(9):e1–3.

    Article  CAS  PubMed  Google Scholar 

  11. Rowley D, Houlihan L, McFaul K, Clarke S, Lyons F. A diagnostic dilemma: drug-induced aseptic meningitis in a 45-year-old HIV-positive man. Int J STD AIDS. 2014;25(4):309–11.

    Article  CAS  PubMed  Google Scholar 

  12. Asperilla MO, Smego RA Jr. Eosinophilic meningitis associated with ciprofloxacin. Am J Med. 1989;87(5):589–90.

    Article  CAS  PubMed  Google Scholar 

  13. Fobelo MJ, Corzo Delgado JE, Romero Alonso A, Gomez-Bellver MJ. Aseptic meningitis related to valacyclovir. Ann Pharmacother. 2001;35(1):128–9.

    Article  CAS  PubMed  Google Scholar 

  14. Olin JL, Gugliotta JL. Possible valacyclovir-related neurotoxicity and aseptic meningitis. Ann Pharmacother. 2003;37(12):1814–7.

    Article  PubMed  Google Scholar 

  15. Adair JC, Woodley SL, O’Connell JB, Call GK, Baringer JR. Aseptic meningitis following cardiac transplantation: clinical characteristics and relationship to immunosuppressive regimen. Neurology. 1991;41:249–52.

    Article  CAS  PubMed  Google Scholar 

  16. Ahmed M, Luggen M, Herman JH, Weiss KL, Decourten-Myers G, Quinlan JG, et al. Hypertrophic pachymeningitis in rheumatoid arthritis after adalimumab administration. J Rheumatol. 2006;33(11):2344–6.

    CAS  PubMed  Google Scholar 

  17. Booker MJ, Flint J, Saravana S. Aseptic meningitis in a patient taking etanercept for rheumatoid arthritis: a case report. Cases J. 2008;1(1):364.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Hegde N, Gayomali C, Rich MW. Infliximab-induced headache and infliximab-induced meningitis: two ends of the same spectrum? South Med J. 2005;98(5):564–6.

    Article  PubMed  Google Scholar 

  19. Huys AC, Guerne PA, Horvath J. Rheumatoid meningitis occurring during adalimumab and methotrexate treatment. Joint Bone Spine. 2012;79(1):90–2.

    Article  PubMed  Google Scholar 

  20. Jazeron A, Lallier JC, Rihn B, Thiercelin MC. Aseptic meningitis possibly induced by adalimumab. Joint Bone Spine. 2010;77(6):618–9.

    Article  PubMed  Google Scholar 

  21. Manthey C, Lohse AW, Pace A. Case report of aseptic meningitis in a patient with Crohn’s disease under infliximab therapy. Inflamm Bowel Dis. 2011;17(2):E10.

    Article  PubMed  Google Scholar 

  22. Marotte H, Charrin JE, Miossec P. Infliximab-induced aseptic meningitis. Lancet. 2001;358(9295):1784.

    Article  CAS  PubMed  Google Scholar 

  23. Tissot B, Visée S, Pilette C, Prophette B, Puechal X. Lymphocytic meningitis with infliximab for ulcerative colitis. Gastroenterol Clin Biol. 2006;30(12):1420–2.

    Article  PubMed  Google Scholar 

  24. Cavazzana I, Taraborelli M, Fredi M, Tincani A, Franceschini F. Aseptic meningitis occurring during anti-TNF-alpha therapy in rheumatoid arthritis and ankylosing spondylitis. Clin Exp Rheumatol. 2014;32(5):732–4.

    PubMed  Google Scholar 

  25. Shah R, Shah M, Bansal N, Manocha D. Infliximab-induced aseptic meningitis. Am J Emerg Med. 2014;32(12):1560.e3–4.

    Article  Google Scholar 

  26. Kluger N, Girard C, Gonzalez V, Guillot B, Bessis D. Efalizumab-induced aseptic meningitis. Br J Dermatol. 2007;156(1):189–91.

    Article  CAS  PubMed  Google Scholar 

  27. Rivas-Rodriguez R, Romero-Alonso MM, Gabella-Bazarot E, Sanchez-Gomez E. Efalizumab-induced aseptic meningitis. Farm Hosp. 2007;31(1):70–1.

    Article  CAS  PubMed  Google Scholar 

  28. Scheinfeld N. Efalizumab: a review of events reported during clinical trials and side effects. Expert Opin Drug Saf. 2006;5(2):197–209.

    Article  CAS  PubMed  Google Scholar 

  29. Vey N, Delaunay J, Martinelli G, Fiedler W, Raffoux E, Prebet T, et al. Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia. Oncotarget. 2016;7(22):32532–42.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Baselga J, Pfister D, Cooper MR, Cohen R, Burtness B, Bos M, et al. Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin. J Clin Oncol. 2000;18(4):904–14.

    Article  CAS  PubMed  Google Scholar 

  31. Emani M, Zaiden R Jr. Aseptic meningitis: a rare side effect of cetuximab therapy. J Oncol Pharm Pract. 2013;19(2):178–80.

    Article  CAS  PubMed  Google Scholar 

  32. Feinstein TM, Gibson MK, Argiris A. Cetuximab-induced aseptic meningitis. Ann Oncol. 2009;20(9):1609–10.

    Article  CAS  PubMed  Google Scholar 

  33. Nagovskiy N, Agarwal M, Allerton J. Cetuximab-induced aseptic meningitis. J Thorac Oncol. 2010;5(5):751.

    Article  PubMed  Google Scholar 

  34. Maritaz C, Metz C, Baba-Hamed N, Jardin-Szucs M, Deplanque G. Cetuximab-induced aseptic meningitis: case report and review of a rare adverse event. BMC Cancer. 2016;16:384.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Prasanna D, Elrafei T, Shum E, Strakhan M. More than a headache: a case of cetuximab-induced aseptic meningitis. BMJ Case Rep. 2015;2015.

    Google Scholar 

  36. Ulrich A, Weiler S, Weller M, Rordorf T, Tarnutzer AA. Cetuximab induced aseptic meningitis. J Clin Neurosci. 2015;22(6):1061–3.

    Article  CAS  PubMed  Google Scholar 

  37. Bharath V, Eckert K, Kang M, Chin-Yee IH, Hsia CC. Incidence and natural history of intravenous immunoglobulin-induced aseptic meningitis: a retrospective review at a single tertiary care center. Transfusion. 2015;55(11):2597–605.

    Article  CAS  PubMed  Google Scholar 

  38. Berg R, Fuellenhals E. Aseptic meningitis following therapy with immune globulins: a combination of product features and patient characteristics? Transfusion. 2016;56(12):3021–8.

    Article  CAS  PubMed  Google Scholar 

  39. Cherin P, Marie I, Michallet M, Pelus E, Dantal J, Crave JC, et al. Management of adverse events in the treatment of patients with immunoglobulin therapy: a review of evidence. Autoimmun Rev. 2016;15(1):71–81.

    Article  CAS  PubMed  Google Scholar 

  40. Houitte R, Abgueguen P, Masson C. Salazopyrine-induced aseptic meningitis. Joint Bone Spine. 2009;76(2):216–7.

    Article  PubMed  Google Scholar 

  41. Cohen J-D, Jorgensen C, Sany J. Leflunomide-induced aseptic meningitis. Joint Bone Spine. 2004;71(3):243–5.

    Article  PubMed  Google Scholar 

  42. Hawboldt J, Bader M. Intramuscular methotrexate-induced aseptic meningitis. Ann Pharmacother. 2007;41(11):1906–11.

    Article  CAS  PubMed  Google Scholar 

  43. Tay SH, Lateef A, Cheung PP. Sulphasalazine-induced aseptic meningitis with facial and nuchal edema in a patient with spondyloarthritis. Int J Rheum Dis. 2012;15(4):e71–2.

    Article  PubMed  Google Scholar 

  44. Merrin P, Williams IA. Meningitis associated with sulphasalazine in a patient with Sjogren’s syndrome and polyarthritis. Ann Rheum Dis. 1991;50(9):645–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Alloway JA, Mitchell SR. Sulfasalazine neurotoxicity: a report of aseptic meningitis and a review of the literature. J Rheumatol. 1993;20(2):409–11.

    CAS  PubMed  Google Scholar 

  46. Salouage I, El Aidli S, Cherif F, Kastalli S, Zaiem A, Daghfous R. Sulfasalazine-induced aseptic meningitis with positive rechallenge: a case report and review of the literature. Therapie. 2013;68(6):423–6.

    Article  PubMed  Google Scholar 

  47. Simms KM, Kortepeter C, Avigan M. Lamotrigine and aseptic meningitis. Neurology. 2012;78(12):921–7.

    Article  CAS  PubMed  Google Scholar 

  48. Green MA, Abraham MN, Horn AJ, Yates TE, Egbert M, Sharma A. Lamotrigine-induced aseptic meningitis: a case report. Int Clin Psychopharmacol. 2009;24(3):159–61.

    Article  PubMed  Google Scholar 

  49. Kilfoyle DH, Anderson NE, Wallis WE, Nicholls DW. Recurrent severe aseptic meningitis after exposure to lamotrigine in a patient with systemic lupus erythematosus. Epilepsia. 2005;46(2):327–8.

    Article  PubMed  Google Scholar 

  50. Lee SHYM, Kim T, et al. Lamotrigine-induced hypersensitivity syndrome accompanied with aseptic meningitis. J Asthma Allergy Clin Immunol. 2007;27:140–2.

    Google Scholar 

  51. Nesseler N, Polard E, Arvieux C, Coquerel N, Michelet C, Tattevin P. Aseptic meningitis associated with lamotrigine: report of two cases. Eur J Neurol. 2007;14(12):e3–4.

    Article  CAS  PubMed  Google Scholar 

  52. Boot B. Recurrent lamotrigine-induced aseptic meningitis. Epilepsia. 2009;50(4):968–9.

    Article  PubMed  Google Scholar 

  53. Hilton E, Stroh EM. Aseptic meningitis associated with administration of carbamazepine. J Infect Dis. 1989;159(2):363–4.

    Article  CAS  PubMed  Google Scholar 

  54. Simon LT, Hsu B, Adornato BT. Carbamazepine-induced aseptic meningitis. Ann Intern Med. 1990;112(8):627–8.

    Article  CAS  PubMed  Google Scholar 

  55. Hemet C, Chassagne P, Levade MH, Heron F, Fortier-Beaulieu M, Doucet J, et al. Aseptic meningitis secondary to carbamazepine treatment of manic-depressive illness. Am J Psychiatry. 1994;151(9):1393.

    CAS  PubMed  Google Scholar 

  56. Dang CT, Riley DK. Aseptic meningitis secondary to carbamazepine therapy. Clin Infect Dis. 1996;22(4):729–30.

    Article  CAS  PubMed  Google Scholar 

  57. Mathanasenarajah G, Hoi A. Trimethoprim-induced aseptic meningitis: a reminder case review. Int J Rheum Dis. 2015.

    Google Scholar 

  58. Quinn JP, Weinstein RA, Caplan LR. Eosinophilic meningitis and ibuprofen therapy. Neurology. 1984;34(1):108–9.

    Article  CAS  PubMed  Google Scholar 

  59. Weksler BB, Lehany AM. Naproxen-induced recurrent aseptic meningitis. DICP. 1991;25(11):1183–4.

    Article  CAS  PubMed  Google Scholar 

  60. Tunkel AR, Starr K. Trimethoprim-sulfamethoxazole-associated aseptic meningitis. Am J Med. 1990;88(6):696–7.

    Article  CAS  PubMed  Google Scholar 

  61. Jurado R, Carpenter SL, Rimland D. Case reports: trimethoprim-sulfamethoxazole-induced meningitis in patients with HIV infection. Am J Med Sci. 1996;312(1):27–9.

    CAS  PubMed  Google Scholar 

  62. Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann Intern Med. 1994;121(4):259–62.

    Article  CAS  PubMed  Google Scholar 

  63. Repplinger MD, Falk PM. Trimethoprim-sulfamethoxazole-induced aseptic meningitis. Am J Emerg Med. 2011;29(2):242 e3–5.

    Article  Google Scholar 

  64. Rodriguez SC, Olguin AM, Miralles CP, Viladrich PF. Characteristics of meningitis caused by Ibuprofen: report of 2 cases with recurrent episodes and review of the literature. Medicine (Baltimore). 2006;85(4):214–20.

    Article  Google Scholar 

  65. Eustace S, Buff B. Magnetic resonance imaging in drug-induced meningitis. Can Assoc Radiol J. 1994;45(6):463–5.

    CAS  PubMed  Google Scholar 

  66. Yasuda Y, Akiguchi I, Kameyama M. Sulindac-induced aseptic meningitis in mixed connective tissue disease. Clin Neurol Neurosurg. 1989;91(3):257–60.

    Article  CAS  PubMed  Google Scholar 

  67. Obermoser G, Bellmann R, Pfausler B, Schmutzhard E, Sepp N. Aseptic meningo-encephalitis related to dexibuprofen use in a patient with systemic lupus erythematosus: a case report with MR findings. Lupus. 2002;11(7):451–3.

    Article  CAS  PubMed  Google Scholar 

  68. Lorino GD, Hardin JG Jr. Sulindac-induced meningitis in mixed connective tissue disease. South Med J. 1983;76(9):1185–7.

    Article  CAS  PubMed  Google Scholar 

  69. Lawson JM, Grady MJ. Ibuprofen-induced aseptic meningitis in a previously healthy patient. West J Med. 1985;143(3):386–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  70. Mandell BF, Raps EC. Severe systemic hypersensitivity reaction to ibuprofen occurring after prolonged therapy. Am J Med. 1987;82(4):817–20.

    Article  CAS  PubMed  Google Scholar 

  71. Gordon MF, Allon M, Coyle PK. Drug-induced meningitis. Neurology. 1990;40(1):163–4.

    Article  CAS  PubMed  Google Scholar 

  72. Fernandez-de-las-Penas C, Palacios-Cena D, Salom-Moreno J, Lopez-de-Andres A, Hernandez-Barrera V, Jimenez-Trujillo I, et al. Has the prevalence of migraine changed over the last decade (2003-2012)? A Spanish population-based survey. PLoS One. 2014;9(10):e110530.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  73. Weder-Cisneros ND, Tellez-Zenteno JF, Cardiel MH, Guibert-Toledano M, Cabiedes J, Velasquez-Paz AL, et al. Prevalence and factors associated with headache in patients with systemic lupus erythematosus. Cephalalgia. 2004;24(12):1031–44.

    Article  CAS  PubMed  Google Scholar 

  74. Cano Vargas-Machuca E, Mondejar-Marin B, Navarro-Munoz S, Perez-Molina I, Garrido-Robres JA, Alvarez-Tejerina A. Recurrent aseptic meningitis secondary to taking ibuprofen and ketorolac. Rev Neurol. 2006;42(4):217–9.

    CAS  PubMed  Google Scholar 

  75. Joffe AM, Farley JD, Linden D, Goldsand G. Trimethoprim-sulfamethoxazole-associated aseptic meningitis: case reports and review of the literature. Am J Med. 1989;87(3):332–8.

    Article  CAS  PubMed  Google Scholar 

  76. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.

    Article  CAS  PubMed  Google Scholar 

  77. Ishiguro A, Suzuki Y, Inaba Y, Fukushima K, Komiyama A, Koeffler HP, et al. The production of IL-8 in cerebrospinal fluid in aseptic meningitis of children. Clin Exp Immunol. 1997;109(3):426–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  78. Martin NG, Iro MA, Sadarangani M, Goldacre R, Pollard AJ, Goldacre MJ. Hospital admissions for viral meningitis in children in England over five decades: a population-based observational study. Lancet Infect Dis. 2016;16(11):1279–87.

    Article  PubMed  Google Scholar 

  79. Widener HL, Littman BH. Ibuprofen-induced meningitis in systemic lupus erythematosus. JAMA. 1978;239(11):1062–4.

    Article  CAS  PubMed  Google Scholar 

  80. Kim JM, Kim KJ, Yoon HS, Kwok SK, Ju JH, Park KS, et al. Meningitis in Korean patients with systemic lupus erythematosus: analysis of demographics, clinical features and outcomes; experience from affiliated hospitals of the Catholic University of Korea. Lupus. 2011;20(5):531–6.

    Article  PubMed  Google Scholar 

  81. Baizabal-Carvallo JF, Delgadillo-Marquez G, Estanol B, Garcia-Ramos G. Clinical characteristics and outcomes of the meningitides in systemic lupus erythematosus. Eur Neurol. 2009;61(3):143–8.

    Article  PubMed  Google Scholar 

  82. Kivity S, Agmon-Levin N, Zandman-Goddard G, Chapman J, Shoenfeld Y. Neuropsychiatric lupus: a mosaic of clinical presentations. BMC Med. 2015;13:43.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Horizon AA, Wallace DJ. Risk:benefit ratio of nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus. Expert Opin Drug Saf. 2004;3(4):273–8.

    Article  CAS  PubMed  Google Scholar 

  84. Rossi R, Valeria Saddi M. Subacute aseptic meningitis as neurological manifestation of primary Sjogren’s syndrome. Clin Neurol Neurosurg. 2006;108(7):688–91.

    Article  PubMed  Google Scholar 

  85. Teixeira F, Moreira I, Silva AM, Vasconcelos C, Farinha F, Santos E. Neurological involvement in Primary Sjogren Syndrome. Acta Reumatologica Portuguesa. 2013;38(1):29–36.

    PubMed  Google Scholar 

  86. Cifelli A, Vaithianathar L. Syndrome of transient headache and neurological deficits with cerebrospinal fluid lymphocytosis (HaNDL). BMJ Case Rep. 2011;2011.

    Google Scholar 

  87. Samuelson CO Jr, Williams HJ. Ibuprofen-associated aseptic meningitis in systemic lupus erythematosus. West J Med. 1979;131(1):57–9.

    PubMed  PubMed Central  Google Scholar 

  88. Bernstein RF. Ibuprofen-related meningitis in mixed connective tissue disease. Ann Intern Med. 1980;92(2 Pt 1):206–7.

    Article  CAS  PubMed  Google Scholar 

  89. Ballas ZK, Donta ST. Sulindac-induced aseptic meningitis. Arch Intern Med. 1982;142(1):165–6.

    Article  CAS  PubMed  Google Scholar 

  90. Auriel E, Regev K, Korczyn AD. Nonsteroidal anti-inflammatory drugs exposure and the central nervous system. Handb Clin Neurol. 2014;119:577–84.

    Article  PubMed  Google Scholar 

  91. Brooks PM, Day RO. Nonsteroidal antiinflammatory drugs—differences and similarities. N Engl J Med. 1991;324(24):1716–25.

    Article  CAS  PubMed  Google Scholar 

  92. Bonnel RA, Villalba ML, Karwoski CB, Beitz J. Aseptic meningitis associated with rofecoxib. Arch Intern Med. 2002;162(6):713–5.

    Article  PubMed  Google Scholar 

  93. Davis BJ, Thompson J, Peimann A, Bendixen BH. Drug-induced aseptic meningitis caused by two medications. Neurology. 1994;44(5):984–5.

    Article  CAS  PubMed  Google Scholar 

  94. Ruppert GB, Barth WF. Tolmetin-induced aseptic meningitis. JAMA. 1981;245(1):67–8.

    Article  CAS  PubMed  Google Scholar 

  95. Ashwath ML, Katner HP. Recurrent aseptic meningitis due to different non-steroidal anti-inflammatory drugs including rofecoxib. Postgrad Med J. 2003;79(931):295–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Berliner S, Weinberger A, Shoenfeld Y, Sandbank U, Hazaz B, Joshua H, et al. Ibuprofen may induce meningitis in (NZB X NZW)F1 mice. Arthritis Rheum. 1985;28(1):104–7.

    Article  CAS  PubMed  Google Scholar 

  97. Shoenfeld Y, Livni E, Shaklai M, Pinkhas J. Sensitization to ibuprofen in systemic lupus erythematosus. JAMA. 1980;244(6):547–8.

    Article  CAS  PubMed  Google Scholar 

  98. Moreno-Ancillo A, Gil-Adrados AC, Jurado-Palomo J. Ibuprofen-induced aseptic meningoencephalitis confirmed by drug challenge. J Investig Allergol Clin Immunol. 2011;21(6):484–7.

    CAS  PubMed  Google Scholar 

  99. Bluth MH, Beleza P, Hajee F, Jordao MJ, Figueiredo J, Almeida F, et al. IgE-mediated hypersensitivity after ibuprofen administration. Ann Clin Lab Sci. 2007;37(4):362–5.

    CAS  PubMed  Google Scholar 

  100. Chez M, Sila CA, Ransohoff RM, Longworth DL, Weida C. Ibuprofen-induced meningitis: detection of intrathecal IgG synthesis and immune complexes. Neurology. 1989;39(12):1578–80.

    Article  CAS  PubMed  Google Scholar 

  101. Gilbert GJ, Eichenbaum HW. Ibuprofen-induced meningitis in an elderly patient with systemic lupus erythematosus. South Med J. 1989;82(4):514–5.

    Article  CAS  PubMed  Google Scholar 

  102. Periard D, Mayor C, Aubert V, Spertini F. Recurrent ibuprofen-induced aseptic meningitis: evidence against an antigen-specific immune response. Neurology. 2006;67(3):539–40.

    Article  CAS  PubMed  Google Scholar 

  103. Thaunat O, Gilquin J, Lazareth I, Priollet P. Amoxicillin-induced aseptic meningo-encephalitis. Allergy. 2003;58(7):687–8.

    Article  CAS  PubMed  Google Scholar 

  104. Derbes SJ. Trimethoprim-induced aseptic meningitis. JAMA. 1984;252(20):2865–6.

    Article  CAS  PubMed  Google Scholar 

  105. Pestalozzi BC, Brignoli S. Trastuzumab in CSF. J Clin Oncol. 2000;18(11):2349–51.

    Article  CAS  PubMed  Google Scholar 

  106. Verma R, Bharti K. Toll like receptor 3 and viral infections of nervous system. J Neurol Sci. 2017;372:40–8.

    Article  CAS  PubMed  Google Scholar 

  107. Bohland M, Kress E, Stope MB, Pufe T, Tauber SC, Brandenburg LO. Lack of toll-like receptor 2 results in higher mortality of bacterial meningitis by impaired host resistance. J Neuroimmunol. 2016;299:90–7.

    Article  PubMed  CAS  Google Scholar 

  108. Orbach H, Katz U, Sherer Y, Shoenfeld Y. Intravenous immunoglobulin: adverse effects and safe administration. Clin Rev Allergy Immunol. 2005;29(3):173–84.

    Article  CAS  PubMed  Google Scholar 

  109. Kemmotsu Y, Nakayama T, Matsuura H, Saji T. Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease. Pediatr Rheumatol Online J. 2011;9:28.

    Article  PubMed  PubMed Central  Google Scholar 

  110. Jarius S, Eichhorn P, Albert MH, Wagenpfeil S, Wick M, Belohradsky BH, et al. Intravenous immunoglobulins contain naturally occurring antibodies that mimic antineutrophil cytoplasmic antibodies and activate neutrophils in a TNFalpha-dependent and Fc-receptor-independent way. Blood. 2007;109(10):4376–82.

    Article  CAS  PubMed  Google Scholar 

  111. Shah BK, O’Keefe S. Pemetrexed induced aseptic meningitis. Acta Oncol. 2012;51(3):399–400.

    Article  CAS  PubMed  Google Scholar 

  112. Flasshove M, Schutte HJ, Kellner R, Hoffken K, Seeber S. Meningeal fluid granulocytosis after cytarabine. Eur J Cancer. 1992;28(1):243.

    Article  CAS  PubMed  Google Scholar 

  113. Pease CL, Horton TM, McClain KL, Kaplan SL. Aseptic meningitis in a child after systemic treatment with high dose cytarabine. Pediatr Infect Dis J. 2001;20(1):87–9.

    Article  CAS  PubMed  Google Scholar 

  114. Thordarson H, Talstad I. Acute meningitis and cerebellar dysfunction complicating high-dose cytosine arabinoside therapy. Acta Med Scand. 1986;220(5):493–5.

    Article  CAS  PubMed  Google Scholar 

  115. Nair J, Stacy M. Aseptic meningitis associated with salicylate overdose. Psychosomatics. 1993;34(4):372.

    Article  CAS  PubMed  Google Scholar 

  116. Heinzlef O, Moguilewski A, Roullet E. Acute aseptic meningitis after hepatitis B vaccination. Presse Med. 1997;26(7):328.

    CAS  PubMed  Google Scholar 

  117. Herlihy TE. Phenazopyridine and aseptic meningitis. Ann Intern Med. 1987;106(1):172–3.

    Article  CAS  PubMed  Google Scholar 

  118. Lafaurie M, Dixmier A, Molina JM. Aseptic meningitis associated with intravenous administration of dexchlorpheniramine. Ann Med Interne (Paris). 2003;154(3):179–80.

    Google Scholar 

  119. Mathian A, Amoura Z, Piette JC. Pentoxifylline-induced aseptic meningitis in a patient with mixed connective tissue disease. Neurology. 2002;59(9):1468–9.

    Article  PubMed  Google Scholar 

  120. Galindo Bonilla PA, Sanchez Rodriguez N, Castro Jimenez A, Munoz-Torrero Rodriguez JJ, Bellon Heredia T, Feo Brito F. Aseptic meningitis induced by vitamin B complex. J Investig Allergol Clin Immunol. 2012;22(3):225–6.

    CAS  PubMed  Google Scholar 

  121. Barbot F, Danan-Causanski S, Chaouat D, Thuong M. Aseptic meningitis after ranitidine treatment for systemic lupus erythematosus. Presse Med. 1999;28(35):1938.

    CAS  PubMed  Google Scholar 

  122. Durand JM, Suchet L, Morange S, Michel B. Ranitidine and aseptic meningitis. BMJ. 1996;312(7035):886.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  123. Duchene DA, Smith CP, Goldfarb RA. Allopurinol induced meningitis. J Urol. 2000;164(6):2028.

    Article  CAS  PubMed  Google Scholar 

  124. Greenberg LE, Nguyen T, Miller SM. Suspected allopurinol-induced aseptic meningitis. Pharmacotherapy. 2001;21(8):1007–9.

    Article  CAS  PubMed  Google Scholar 

  125. Smith RM, Schaefer MK, Kainer MA, Wise M, Finks J, Duwve J, et al. Fungal infections associated with contaminated methylprednisolone injections. N Engl J Med. 2013;369(17):1598–609.

    Article  CAS  PubMed  Google Scholar 

  126. Codipietro L, Maino P. Aseptic arachnoiditis in a patient treated with intrathecal morphine infusion: symptom resolution on switch to ziconotide. Neuromodulation. 2015;18(3):217–20. discussion 20.

    Article  PubMed  Google Scholar 

  127. Bensmail D, Peskine A, Denys P, Bernard L, Bussel B. Aseptic meningitis after intrathecal baclofen injection. Spinal Cord. 2006;44(5):330–3.

    Article  CAS  PubMed  Google Scholar 

  128. Gutknecht DR. Chemical meningitis following epidural injections of corticosteroids. Am J Med. 1987;82(3):570.

    Article  CAS  PubMed  Google Scholar 

  129. Tateno F, Sakakibara R, Kishi M, Ogawa E. Bupivacaine-induced chemical meningitis. J Neurol. 2010;257(8):1327–9.

    Article  PubMed  Google Scholar 

  130. Mamishi S, Sarkardeh M, Pourakbari B, Keshavarz Valian S, Sabouni F, Mahmoudi S. Aseptic meningitis after measles-mumps-rubella (MMR) vaccination. Br J Biomed Sci. 2016;73(2):84–6.

    Article  PubMed  Google Scholar 

  131. Ainiala H, Loukkola J, Peltola J, Korpela M, Hietaharju A. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology. 2001;57(3):496–500.

    Article  CAS  PubMed  Google Scholar 

  132. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. Rheumatology (Oxford). 2002;41(6):605–18.

    Article  CAS  Google Scholar 

  133. Lee JH, Lee JY, Lee YJ, Park DW, Kim YS, Kim HY. Noninfectious meningitis caused by systemic lupus erythematosus: a case series of 4 patients. J Comput Assist Tomogr. 2016;40(3):424–7.

    Article  PubMed  Google Scholar 

  134. Balkan II, Albayram S, Ozaras R, Yilmaz MH, Ozbayrak M, Mete B, et al. Spontaneous intracranial hypotension syndrome may mimic aseptic meningitis. Scand J Infect Dis. 2012;44(7):481–8.

    Article  CAS  PubMed  Google Scholar 

  135. Mokri B. Spontaneous low pressure, low CSF volume headaches: spontaneous CSF leaks. Headache. 2013;53(7):1034–53.

    Article  PubMed  Google Scholar 

  136. Alexander EL, Alexander GE. Aseptic meningoencephalitis in primary Sjogren’s syndrome. Neurology. 1983;33(5):593–8.

    Article  CAS  PubMed  Google Scholar 

  137. Ishida K, Uchihara T, Mizusawa H. Recurrent aseptic meningitis: a new CSF complication of Sjogren’s syndrome. J Neurol. 2007;254(6):806–7.

    Article  PubMed  Google Scholar 

  138. Krumholz A, Stern BJ. Neurologic manifestations of sarcoidosis. Handb Clin Neurol. 2014;119:305–33.

    Article  PubMed  Google Scholar 

  139. Held EP, Iglesia EA, Johnson AS, Fang JY, Wilson MH, Abel TW, et al. Neurosarcoidosis presenting as aseptic meningitis in an immunosuppressed renal transplant recipient. Transplantation. 2016;100(10):e96–e100.

    Article  PubMed  Google Scholar 

  140. Miller JJ, Venna N, Siva A. Neuro-Behcet disease and autoinflammatory disorders. Semin Neurol. 2014;34(4):437–43.

    Article  PubMed  Google Scholar 

  141. Dutra LA, Goncalves CR, Braga-Neto P, Pedroso JL, Gabbai AA, Barsottini OG, et al. Atypical manifestations in Brazilian patients with neuro-Behcet’s disease. J Neurol. 2012;259(6):1159–65.

    Article  PubMed  Google Scholar 

  142. Sakakibara R, Koide N, Kishi M, Ogawa E, Shirai K. Aseptic meningitis as the sole manifestation of Behcet’s disease. Neurol Sci. 2009;30(5):405–7.

    Article  PubMed  Google Scholar 

  143. Siva A, Saip S. The spectrum of nervous system involvement in Behcet’s syndrome and its differential diagnosis. J Neurol. 2009;256(4):513–29.

    Article  PubMed  Google Scholar 

  144. Bhattacharyya S, Berkowitz AL. Primary angiitis of the central nervous system: avoiding misdiagnosis and missed diagnosis of a rare disease. Pract Neurol. 2016;16(3):195–200.

    Article  PubMed  Google Scholar 

  145. Powers WJ. Primary angiitis of the central nervous system: diagnostic criteria. Neurol Clin. 2015;33(2):515–26.

    Article  PubMed  Google Scholar 

  146. Chamberlain MC. Neoplastic meningitis. Handb Clin Neurol. 2012;105:757–66.

    Article  PubMed  Google Scholar 

  147. Hueng DY, An YC. Neoplastic meningitis. J Neurosurg. 2012;117(5):979. author reply −80.

    Article  PubMed  Google Scholar 

  148. Greco A, Fusconi M, Gallo A, Turchetta R, Marinelli C, Macri GF, et al. Vogt-Koyanagi-Harada syndrome. Autoimmun Rev. 2013;12(11):1033–8.

    Article  CAS  PubMed  Google Scholar 

  149. Smit J, Berman DC, Nielsen H. Vogt-Koyanagi-Harada syndrome: a rare but important differential diagnosis of viral meningitis. Scand J Infect Dis. 2012;44(2):157–9.

    Article  PubMed  Google Scholar 

  150. Berg MJ, Williams LS. The transient syndrome of headache with neurologic deficits and CSF lymphocytosis. Neurology. 1995;45(9):1648–54.

    Article  CAS  PubMed  Google Scholar 

  151. Guillan M, DeFelipe-Mimbrera A, Alonso-Canovas A, Matute MC, Vera R, Cruz-Culebras A, et al. The syndrome of transient headache and neurological deficits with cerebrospinal fluid lymphocytosis mimicking an acute stroke. Eur J Neurol. 2016;23(7):1235–40.

    Article  CAS  PubMed  Google Scholar 

  152. Babi MA, Applebee A, Shapiro R, Waheed W. Syndrome of transient headache and neurologic deficits with cerebrospinal fluid lymphocytosis presenting as acute neurological emergencies. Cephalalgia. 2016.

    Google Scholar 

  153. Gomez-Aranda F, Canadillas F, Marti-Masso JF, Diez-Tejedor E, Serrano PJ, Leira R, et al. Pseudomigraine with temporary neurological symptoms and lymphocytic pleocytosis. A report of 50 cases. Brain. 1997;120(Pt 7):1105–13.

    Article  PubMed  Google Scholar 

  154. Serrano-Castro PJ, Amrani Y, Olivares-Romero J. Cerebral hemodynamics in the syndrome of pseudomigraine with csf-pleocytosis:a transcranial doppler study. Rev Neurol. 2000;31(5):407–11.

    CAS  PubMed  Google Scholar 

  155. Kurtuncu M, Kaya D, Zuliani L, Erdag E, Icoz S, Ugurel E, et al. CACNA1H antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL). Cephalalgia. 2013;33(2):123–9.

    Article  PubMed  Google Scholar 

  156. Dash GK, Thomas B, Nair M, Radhakrishnan A. Clinico-radiological spectrum and outcome in idiopathic hypertrophic pachymeningitis. J Neurol Sci. 2015;350(1-2):51–60.

    Article  PubMed  Google Scholar 

  157. Velamati R, Hageman JR, Bartlett A. Meningitis secondary to ruptured epidermoid cyst: case-based review. Pediatr Ann. 2013;42(6):248–51.

    Article  PubMed  Google Scholar 

  158. Wang ZJ, CQ P, Wang ZJ, Zhang JT, Wang XQ, Yu SY, et al. Meningoencephalitis or meningitis in relapsing polychondritis: four case reports and a literature review. J Clin Neurosci. 2011;18(12):1608–15.

    Article  CAS  PubMed  Google Scholar 

  159. Lidove O, Chauveheid MP, Caillaud C, Froissart R, Benoist L, Alamowitch S, et al. Aseptic meningitis and ischaemic stroke in Fabry disease. Int J Clin Pract. 2009;63(11):1663–7.

    Article  CAS  PubMed  Google Scholar 

  160. Varona JF. Neurological manifestations as presentation of infectious endocarditis. An Med Interna. 2007;24(9):439–41.

    CAS  PubMed  Google Scholar 

  161. Bakhtevari MH, Sharifi G, Jabbari R, Shafizad M, Rezaei M, Samadian M, et al. Giant leaking colloid cyst presenting with aseptic meningitis: review of the literature and report of a case. World Neurosurg. 2015;84(6):1997–2001.

    Article  PubMed  Google Scholar 

  162. Hai J, Zhang L, Wan JF, Su SH, Wang F, Zhang GY. A dural arteriovenous fistula in cavernous sinus developed from viral meningitis. Acta Neurol Belg. 2011;111(2):146–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain

    Germán Morís M.D.

  2. Department of Neurology, Hospital de Galdakao-Usansolo, Galdakao, Vizcaya, Spain

    Juan Carlos García-Moncó M.D.

Authors
  1. Germán Morís M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Juan Carlos García-Moncó M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Juan Carlos García-Moncó M.D. .

Editor information

Editors and Affiliations

  1. Department of Neurology, Hospital de Galdakao-Usansolo, Galdacano, Vizcaya, Spain

    Juan Carlos García-Moncó

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing Switzerland

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Morís, G., García-Moncó, J.C. (2018). Drug-Induced Aseptic Meningitis and Other Mimics. In: García-Moncó, J. (eds) CNS Infections. Springer, Cham. https://doi.org/10.1007/978-3-319-70296-4_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-70296-4_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-70295-7

  • Online ISBN: 978-3-319-70296-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation